glp-1 drugs examples List of Receptor Agonists for Diabetes & Weight Loss GLP-1 medications compared: Benefits and

Real-world Evidence: There is mounting evidence that GLP-1 agonists administered for diabetes or obesity correspond to reduced addiction risk

11 Cardiovascular risk reduction In a systematic review and meta-analysis of cardiovascular outcome trials, use of GLP-1RAs reduced major adverse cardiac events (HR 0.88

All individual risk ratios were calculated using Microsoft Excel (Microsoft Corporation, Redmond, WA)

Serial analyses of the metabolic profile showed consistently high HbA1c levels and body weight loss among GLP-1 RAs users

doi: 10.1016/j.ejphar.2016.10.016 [DOI] [PubMed] [Google Scholar] 153

GLP-1R is a B-class GPCR that acts on both Gq and Gs signaling, comparable to the other incretin hormone glucose-dependent insulinotropic polypeptides (GIPs), though they only activate the Gs signaling pathway